These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17984370)

  • 1. LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling.
    Paulis L; Simko F
    Hypertension; 2007 Dec; 50(6):1009-11. PubMed ID: 17984370
    [No Abstract]   [Full Text] [Related]  

  • 2. LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation.
    Ruiz-Hurtado G; Fernández-Velasco M; Mourelle M; Delgado C
    Hypertension; 2007 Dec; 50(6):1049-56. PubMed ID: 17984372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S; Kobayashi N; Yagi H; Mori Y; Matsuoka H
    J Cardiovasc Pharmacol; 2006 May; 47(5):629-35. PubMed ID: 16775500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice.
    Carnicer R; Guillén N; Arbonés-Mainar JM; Navarro MA; Guzmán MA; Barranquero C; Arnal C; Gascón S; Acín S; Mourelle M; Osada J
    Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):489-500. PubMed ID: 19050853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitric oxide and heart failure].
    Yoshioka T; Takahashi M; Ikeda U
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():527-30. PubMed ID: 15506442
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G; Pena E; Padró T; Badimon L
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effect of a new nitric oxide donor (LA419) on experimental thrombogenesis.
    Hernandez MR; Tonda R; Arderiu G; Pino M; Serradell M; Escolar G
    Eur J Clin Invest; 2005 May; 35(5):337-42. PubMed ID: 15860046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects.
    Zafar MU; Vilahur G; Choi BG; Ibanez B; Viles-Gonzalez JF; Salas E; Badimon JJ
    J Thromb Haemost; 2007 Jun; 5(6):1195-200. PubMed ID: 17389007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy with organic nitrates: the pros and cons of nitric oxide replacement therapy.
    Gori T; Parker JD
    J Am Coll Cardiol; 2004 Aug; 44(3):632-4. PubMed ID: 15358032
    [No Abstract]   [Full Text] [Related]  

  • 10. Genistein prevents myocardial hypertrophy in 2-kidney 1-clip renal hypertensive rats by restoring eNOS pathway.
    Li J; Xie ZZ; Tang YB
    Pharmacology; 2010; 86(4):240-8. PubMed ID: 20938214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and airway reactivity.
    Strapkova A; Nosalova G
    Bratisl Lek Listy; 2001; 102(8):345-50. PubMed ID: 11763662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitric oxide donor LA-419 [S-(6-Nitro-oxi-hexahydro-furo[3,2-b]furan-3-1-il)thioacetate] prevents intestinal dysmotility, bacterial translocation, and inflammation in a rat model of enteritis.
    Porras M; Martín MT; Terán E; Mourelle M; Vergara P
    J Pharmacol Exp Ther; 2008 Feb; 324(2):740-8. PubMed ID: 17959746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and lung injury in the rat.
    Mourelle M; Martin MT; Giménez F
    Proc West Pharmacol Soc; 2011; 54():89-93. PubMed ID: 22423590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelium and nitric oxide].
    Garaliene V
    Medicina (Kaunas); 2008; 44(7):564-9. PubMed ID: 18695354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nitric oxide donor LA 419 decreases ischemic brain damage.
    Serrano J; Fernández AP; Martínez-Murillo R; Alonso D; Rodrigo J; Salas E; Mourelle M; Martínez A
    Int J Mol Med; 2007 Feb; 19(2):229-36. PubMed ID: 17203196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential efficacy of nitric oxide for cervical ripening in pregnancy at term.
    Chanrachakul B; Herabutya Y; Punyavachira P
    Int J Gynaecol Obstet; 2000 Dec; 71(3):217-9. PubMed ID: 11102606
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo.
    Agvald P; Adding LC; Gustafsson LE; Persson MG
    Eur J Pharmacol; 1999 Dec; 385(2-3):137-45. PubMed ID: 10607869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nitric oxide on prolactin release induced by immobilization stress in rats.
    Luras A; Nonaka KO
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1125-8. PubMed ID: 12452534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.